Celularity (CELU) News
NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.463-0.0049 (-1.05%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CELU news summary
We found 2 recent headlines mentioning Celularity (CELU): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, CELU is down 1.05% at $0.463. The most recent story, "Celularity Inc. Announces Exclusive Peptide API Manufacturing Collaboration with Vesalius Longevity Labs on October 29, 2026", was published by Nasdaq on Oct 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Celularity headlines
- Celularity Inc. Announces Exclusive Peptide API Manufacturing Collaboration with Vesalius Longevity Labs on October 29, 2026Celularity Inc. announced an exclusive manufacturing and commercial collaboration with Vesalius Longevity Labs Inc. on October 29, 2026. Under the agreement, Celularity will serve as the exclusive…Nasdaq
- Weekly Buzz: GILD, ROIV Win FDA Nod; BHVN, LLY Strike Deal; SYRE Misses Monotherapy Goal(RTTNews) - This week's biotech landscape saw a wave of regulatory approvals across HIV, rare diseases, immunology, and diagnostics, alongside strategic licensing deals, manufacturing collaborations,…NasdaqAMGN, AZN, BCRX, BHVN